Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results
(NASDAQ: FULC) Delayed: 3.77 +0.07 (1.89%)
Previous Close $3.70    52 Week High
Open $3.69    52 Week Low
Day High $3.89    P/E N/A 
Day Low $3.63    EPS
Volume 2,868,623